BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YRD
4726
Yiren Digital
YRD
$98M
| $182K | ﹤0.01% |
30,267
+17,121
| +130% | +$73.4K |
|
4727
Bank Of The James
BOTJ
$123M
| $181K | ﹤0.01% |
11,285
+9,521
| +540% | +$144K |
|
|
IRD
4728
Opus Genetics
IRD
$306M
| $181K | ﹤0.01% |
34,427
+32,220
| +1,460% | +$160K |
|
4729
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.6B
| $180K | ﹤0.01% |
3,400
-166
| -5% | -$8.59K |
|
4730
Willamette Valley Vineyards
WVVI
$12.7M
| $180K | ﹤0.01% |
13,185
+12,391
| +1,561% | +$156K |
|
4731
Gilat Satellite Networks
GILT
$834M
| $178K | ﹤0.01% |
17,524
+9,095
| +108% | +$90.6K |
|
4732
Arcadia Biosciences
RKDA
$1.36M
| $178K | ﹤0.01% |
1,498
+846
| +130% | +$92.2K |
|
|
SSKN
4733
DELISTED
Strata Skin Sciences
SSKN
| $178K | ﹤0.01% |
11,422
-999
| -8% | -$15.5K |
|
4734
Telecom Argentina
TEO
$6.03B
| $178K | ﹤0.01% |
33,389
-3,398,666
| -99% | -$17.9M |
|
4735
Millicom
TIGO
$16B
| $178K | ﹤0.01% |
4,504
| – | – |
|
|
THMO
4736
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $178K | ﹤0.01% |
1,492
-622
| -29% | -$73.5K |
|
4737
Kewaunee Scientific
KEQU
$102M
| $177K | ﹤0.01% |
12,227
+5,814
| +91% | +$71.8K |
|
4738
Rezolute
RZLT
$454M
| $177K | ﹤0.01% |
+12,430
| New | +$112K |
|
|
SFBC
4739
Sound Financial Bancorp
SFBC
$112M
| $177K | ﹤0.01% |
3,865
+3,114
| +415% | +$131K |
|
4740
Crexendo
CXDO
$223M
| $175K | ﹤0.01% |
28,554
+17,583
| +160% | +$101K |
|
|
FAT
4741
DELISTED
FAT Brands
FAT
| $174K | ﹤0.01% |
21,472
+8,643
| +67% | +$50.1K |
|
|
HURA
4742
TuHURA Biosciences
HURA
$138M
| $172K | ﹤0.01% |
+43
| New | +$124K |
|
4743
iShares MSCI Turkey ETF
TUR
$200M
| $171K | ﹤0.01% |
8,098
-25,273
| -76% | -$582K |
|
|
KBNT
4744
DELISTED
Kubient, Inc. Common Stock
KBNT
| $171K | ﹤0.01% |
+29,967
| New | +$175K |
|
4745
MediWound
MDWD
$181M
| $170K | ﹤0.01% |
6,341
+6,022
| +1,888% | +$186K |
|
4746
Rocky Mountain Chocolate Factory
RMCF
$7.93M
| $169K | ﹤0.01% |
22,224
+15,171
| +215% | +$94.4K |
|
|
MTVA
4747
MetaVia Inc
MTVA
$7.33M
| $167K | ﹤0.01% |
19
-67
| -78% | -$585K |
|
|
BGIO
4748
DELISTED
BlackRock 2022 Global Income Opportunity Trust
BGIO
| $166K | ﹤0.01% |
17,919
| – | – |
|
|
AVDL
4749
DELISTED
Avadel Pharmaceuticals
AVDL
| $165K | ﹤0.01% |
24,578
-484,706
| -95% | -$3.85M |
|
|
ZNB
4750
Zeta Network Group
ZNB
$551K
| – | – |
0
| – | – |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.